Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-005487
Filing Date
2014-02-06
Accepted
2014-02-06 16:19:13
Documents
1
Period of Report
2014-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd401418.html 3  
1 FORM 3 rrd401418.xml 3 2127
  Complete submission text file 0001181431-14-005487.txt   3472
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address
Johnson David Louis (Reporting) CIK: 0001352238 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 14580384